C-reactive protein in patients with COPD, control smokers and non-smokers

VM Pinto-Plata, H Müllerova, JF Toso, M Feudjo-Tepie… - Thorax, 2006 - thorax.bmj.com
Background: Patients with chronic obstructive pulmonary disease (COPD) have raised serum
levels of C reactive protein (CRP). This may be related directly to COPD and its associated …

Inflammatory changes, recovery and recurrence at COPD exacerbation

WR Perera, JR Hurst, TMA Wilkinson… - European …, 2007 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) exacerbations are associated with increased
airway and systemic inflammation, though relationships between exacerbation recovery, …

Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort

NA Hanania, H Müllerova, NW Locantore… - American journal of …, 2011 - atsjournals.org
Rationale: Depression is prevalent in patients with chronic obstructive pulmonary disease (COPD);
however, its etiology and relationship to the clinical features of COPD are not well …

Cardiovascular comorbidity in COPD: systematic literature review

H Müllerova, A Agusti, S Erqou, DW Mapel - Chest, 2013 - Elsevier
Background Cardiovascular disease (CVD) is common among patients with COPD. However,
it is not clear whether this is due to shared risk factors or if COPD increases the risk for …

Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort

H Müllerova, DJ Maselli, N Locantore, J Vestbo… - Chest, 2015 - Elsevier
OBJECTIVE: Exacerbations of COPD requiring hospital admission have important clinical
and societal implications. We sought to investigate the incidence, recurrence, risk factors, and …

Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)

JK Quint, H Müllerova, RL DiSantostefano, H Forbes… - BMJ open, 2014 - bmjopen.bmj.com
Objectives The optimal method of identifying people with chronic obstructive pulmonary disease
(COPD) from electronic primary care records is not known. We assessed the accuracy of …

Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort

A Agusti, LD Edwards, B Celli… - European …, 2013 - Eur Respiratory Soc
Mullerova developed the study protocol, interpreted study data, contributed to and
reviewed drafts of the manuscript, and approved the final version of the manuscript; DA Lomas …

[HTML][HTML] The natural history of community-acquired pneumonia in COPD patients: a population database analysis

H Müllerova, C Chigbo, GW Hagan, MA Woodhead… - Respiratory …, 2012 - Elsevier
Hana Müllerova and Kourtney Davis are employees of GlaxoSmithKline R&D and own
shares and stok option of GlaxoSmithKline plc. Chuba Cigbo has not conflict of interest. …

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

…, J Toso, K Lee, D Park, J Bilello, H Mullerova… - Thorax, 2007 - thorax.bmj.com
Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory lung
disease associated with significant systemic consequences. Recognition of the systemic …

Treatment trials in young patients with chronic obstructive pulmonary disease and pre–chronic obstructive pulmonary disease patients: time to move forward

…, N Locantore, FD Martinez, H Mullerova… - American journal of …, 2022 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is the end result of a series of dynamic and
cumulative gene–environment interactions over a lifetime. The evolving understanding of …